Towa Pharmaceutical Co., Ltd. (TYO:4553)

Towa Pharmaceutical Revenue

Towa Pharmaceutical had revenue of 65.15B JPY in the quarter ending June 30, 2025, with 4.13% growth. This brings the company's revenue in the last twelve months to 262.18B, up 11.11% year-over-year. In the fiscal year ending March 31, 2025, Towa Pharmaceutical had annual revenue of 259.59B with 13.89% growth.

• Revenue (ttm): 262.18B
• Revenue Growth: +11.11%
• P/S Ratio: 0.55
• Revenue / Employee: 54.76M
• Employees: 4,788
• Market Cap: 143.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	259.59B	31.66B	13.89%
Mar 31, 2024	227.93B	19.08B	9.13%
Mar 31, 2023	208.86B	43.24B	26.11%
Mar 31, 2022	165.62B	10.72B	6.92%
Mar 31, 2021	154.90B	44.52B	40.33%